Women diagnosed with DCIS face a threefold higher risk of breast cancer mortality. Learn the warning signs, treatment options ...

High-risk NMIBC is characterised by poor prognosis, with half of patients recurring despite effective treatment with the ...

Beyond five days’ of statutory sick pay a year, your employer is not obliged to keep paying you if you fall ill ...

Q1 2025 Earnings Call Transcript May 12, 2025 Relmada Therapeutics, Inc. misses on earnings expectations. Reported EPS is $-0 ...

NEW YORK, May 13, 2025 (GLOBE NEWSWIRE) -- Protara Therapeutics, Inc. (Nasdaq: TARA), a clinical-stage company developing ...

Welcome to the Relmada Therapeutics first-quarter 2025 earnings call. (Operator Instructions) As a reminder, this conference is being recorded, and will be available for replay on the location website ...

Research and development expenses for the first quarter of 2025 increased to $9.1 million from $7.7 million for the prior ...

Weight gain combined with late first pregnancy (FP) or nulliparity is associated with an increased risk for breast cancer (BC ...

The 49-year-old, best known for her role as Eve Sopal-Unwin in the BBC soap, told Instagram followers she has completed ...

ImmunityBio, Inc.’s IBRX share price has surged by 10.14%, which has investors questioning if this is right time to sell.

Colin P.N. Dinney, MD, provides some background on translational analyses from the BOND-003 and CORE-001 trials.

Women who experience significant weight gain after the age of 20 and either have their first child after the age of 30 or don ...